NCT06697977 Effects of Phytosterol Supplementation on Liver Function and Inflammatory Status in Patients With Nonalcoholic Fatty Liver Disease Status COMPLETED Phase NA
NCT06501001 Time Restricted Eating (TRE) and High-Intensity Interval Training (HIIT) to Improve Health in Patients With Metabolic Syndrome (METS) Status COMPLETED Phase NA
NCT06112418 A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events Status RECRUITING Phase NA
NCT05972564 The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Status RECRUITING Phase PHASE1/PHASE2
NCT05950282 Determinants of Insulin Sensitivity by Age, Sex, Race/Ethnicity, BMI, and PCOS Diagnosis Status RECRUITING Phase N/A
NCT05834309 Exercise Effects on Health Status in Patients With Severe Mental Illness Status ACTIVE_NOT_RECRUITING Phase NA
NCT05806801 Metabolic Adaptations to Weight Loss With and Without Exercise Status RECRUITING Phase NA
NCT05790564 Almonds to Improve Gut Health and Decrease Inflammation Status ACTIVE_NOT_RECRUITING Phase NA
NCT05242640 Understanding Components of Mind-body Exercise for Physical Activity Engagement in Metabolic Syndrome Status COMPLETED Phase NA
NCT05033119 PROSA: Prolactin, Sex Hormones, Growth and Metabolic Biomarkers in Children and Adolescents on Antipsychotics Status COMPLETED Phase N/A
NCT04974554 FIT Families Multicomponent Obesity Intervention for African American Adolescents Status ACTIVE_NOT_RECRUITING Phase NA
NCT04922970 Strength Training as Prevention and Treatment of Late Effects in Long-term Survivors of Pediatric HSCT. Status COMPLETED Phase NA
NCT04575844 Effects of Exercise and GLP-1 Agonism on Muscle Microvascular Perfusion and Insulin Action in Adults With Metabolic Syndrome Status RECRUITING Phase PHASE4
NCT03794531 Psychosocial, Environmental, and Chronic Disease Trends in Puerto Rico Status RECRUITING Phase N/A
NCT03440736 Comparison of Secukinumab 300 mg Combined With a Lifestyle Intervention to Secukinumab Alone for the Treatment of Moderate to Severe Psoriasis Patients With Concomitant Metabolic Syndrome Status COMPLETED Phase PHASE4
NCT03113994 Statin Monotherapy for Treatment of Endocrine Metabolic Disease Risk Status TERMINATED Phase PHASE2